![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Cspg5 | Rat | (1->4)-beta-D-glucan | multiple interactions | ISO | Cspg5 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CSPG5 mRNA | CTD | PMID:36331819 | Cspg5 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Cspg5 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of CSPG5 mRNA | CTD | PMID:22206623 | Cspg5 | Rat | 17alpha-ethynylestradiol | affects expression | EXP | | 6480464 | Ethinyl Estradiol affects the expression of CSPG5 mRNA | CTD | PMID:20170705 | Cspg5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CSPG5 mRNA | CTD | PMID:11752688 | Cspg5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Cspg5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CSPG5 mRNA | CTD | PMID:26377647 and PMID:28922406 | Cspg5 | Rat | 4-hydroxyphenyl retinamide | decreases expression | ISO | Cspg5 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of CSPG5 mRNA | CTD | PMID:28973697 | Cspg5 | Rat | 4-phenylbutyric acid | increases expression | ISO | CSPG5 (Homo sapiens) | 6480464 | 4-phenylbutyric acid results in increased expression of CSPG5 mRNA | CTD | PMID:14583596 | Cspg5 | Rat | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of CSPG5 mRNA | CTD | PMID:28959563 | Cspg5 | Rat | all-trans-retinoic acid | decreases expression | ISO | CSPG5 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of CSPG5 mRNA | CTD | PMID:21934132 and PMID:33167477 | Cspg5 | Rat | alpha-Zearalanol | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of CSPG5 mRNA | CTD | PMID:35163327 | Cspg5 | Rat | amitrole | decreases expression | EXP | | 6480464 | Amitrole results in decreased expression of CSPG5 mRNA | CTD | PMID:38685447 | Cspg5 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of CSPG5 mRNA | CTD | PMID:16483693 | Cspg5 | Rat | amphotericin B | decreases expression | ISO | CSPG5 (Homo sapiens) | 6480464 | Amphotericin B analog results in decreased expression of CSPG5 mRNA | CTD | PMID:28534445 | Cspg5 | Rat | arsenous acid | decreases expression | ISO | CSPG5 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of CSPG5 mRNA | CTD | PMID:26705709 | Cspg5 | Rat | benzo[a]pyrene | increases expression | ISO | Cspg5 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of CSPG5 mRNA | CTD | PMID:22228805 | Cspg5 | Rat | benzo[a]pyrene | affects methylation | ISO | CSPG5 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of CSPG5 promoter | CTD | PMID:27901495 | Cspg5 | Rat | bexarotene | increases expression | EXP | | 6480464 | bexarotene results in increased expression of CSPG5 mRNA | CTD | PMID:16648578 | Cspg5 | Rat | bisphenol A | affects expression | ISO | CSPG5 (Homo sapiens) | 6480464 | bisphenol A affects the expression of CSPG5 mRNA | CTD | PMID:20170705 | Cspg5 | Rat | bisphenol A | decreases expression | ISO | Cspg5 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of CSPG5 mRNA | CTD | PMID:32156529 | Cspg5 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CSPG5 mRNA | CTD | PMID:30816183 | Cspg5 | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of CSPG5 mRNA | CTD | PMID:25181051 | Cspg5 | Rat | calcidiol | decreases expression | EXP | | 6480464 | Calcifediol deficiency results in decreased expression of CSPG5 mRNA | CTD | PMID:17293106 | Cspg5 | Rat | cerium trichloride | increases expression | ISO | Cspg5 (Mus musculus) | 6480464 | cerous chloride results in increased expression of CSPG5 mRNA | CTD | PMID:23573234 | Cspg5 | Rat | CGP 52608 | multiple interactions | ISO | CSPG5 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to CSPG5 gene] | CTD | PMID:28238834 | Cspg5 | Rat | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of CSPG5 mRNA | CTD | PMID:24386269 | Cspg5 | Rat | cocaine | affects expression | EXP | | 6480464 | Cocaine affects the expression of CSPG5 mRNA and Cocaine affects the expression of CSPG5 protein | CTD | PMID:12358776 | Cspg5 | Rat | coumestrol | multiple interactions | ISO | CSPG5 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CSPG5 mRNA | CTD | PMID:19167446 | Cspg5 | Rat | diarsenic trioxide | decreases expression | ISO | CSPG5 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of CSPG5 mRNA | CTD | PMID:26705709 | Cspg5 | Rat | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of CSPG5 mRNA | CTD | PMID:21266533 | Cspg5 | Rat | dorsomorphin | multiple interactions | ISO | CSPG5 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Cspg5 | Rat | Enterolactone | multiple interactions | ISO | CSPG5 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CSPG5 mRNA | CTD | PMID:19167446 | Cspg5 | Rat | epoxiconazole | increases expression | ISO | Cspg5 (Mus musculus) | 6480464 | epoxiconazole results in increased expression of CSPG5 mRNA | CTD | PMID:35436446 | Cspg5 | Rat | ethanol | increases expression | ISO | Cspg5 (Mus musculus) | 6480464 | Ethanol results in increased expression of CSPG5 mRNA | CTD | PMID:30319688 | Cspg5 | Rat | ethanol | affects splicing | ISO | Cspg5 (Mus musculus) | 6480464 | Ethanol affects the splicing of CSPG5 mRNA | CTD | PMID:30319688 | Cspg5 | Rat | folic acid | decreases expression | ISO | Cspg5 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of CSPG5 mRNA | CTD | PMID:25629700 | Cspg5 | Rat | gentamycin | affects expression | EXP | | 6480464 | Gentamicins affects the expression of CSPG5 mRNA | CTD | PMID:33387578 | Cspg5 | Rat | iron dichloride | decreases expression | ISO | CSPG5 (Homo sapiens) | 6480464 | ferrous chloride results in decreased expression of CSPG5 mRNA | CTD | PMID:35984750 | Cspg5 | Rat | L-ascorbic acid | increases expression | ISO | Cspg5 (Mus musculus) | 6480464 | Ascorbic Acid results in increased expression of CSPG5 mRNA | CTD | PMID:15305145 | Cspg5 | Rat | lead(0) | affects expression | ISO | CSPG5 (Homo sapiens) | 6480464 | Lead affects the expression of CSPG5 mRNA | CTD | PMID:28903495 | Cspg5 | Rat | mercury atom | increases expression | ISO | CSPG5 (Homo sapiens) | 6480464 | Mercury results in increased expression of CSPG5 mRNA | CTD | PMID:16823088 | Cspg5 | Rat | mercury dibromide | decreases expression | ISO | CSPG5 (Homo sapiens) | 6480464 | mercuric bromide results in decreased expression of CSPG5 mRNA | CTD | PMID:26272509 | Cspg5 | Rat | mercury dibromide | multiple interactions | ISO | CSPG5 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CSPG5 mRNA | CTD | PMID:27188386 | Cspg5 | Rat | mercury(0) | increases expression | ISO | CSPG5 (Homo sapiens) | 6480464 | Mercury results in increased expression of CSPG5 mRNA | CTD | PMID:16823088 | Cspg5 | Rat | methylmercury chloride | increases expression | ISO | CSPG5 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of CSPG5 mRNA | CTD | PMID:28001369 | Cspg5 | Rat | panobinostat | multiple interactions | ISO | CSPG5 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CSPG5 mRNA | CTD | PMID:27188386 | Cspg5 | Rat | panobinostat | decreases expression | ISO | CSPG5 (Homo sapiens) | 6480464 | panobinostat results in decreased expression of CSPG5 mRNA | CTD | PMID:26272509 | Cspg5 | Rat | paracetamol | affects expression | ISO | Cspg5 (Mus musculus) | 6480464 | Acetaminophen affects the expression of CSPG5 mRNA | CTD | PMID:17562736 | Cspg5 | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of CSPG5 mRNA | CTD | PMID:33387578 | Cspg5 | Rat | paracetamol | increases expression | ISO | CSPG5 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of CSPG5 mRNA | CTD | PMID:29067470 | Cspg5 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Cspg5 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CSPG5 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of CSPG5 mRNA | CTD | PMID:36331819 | Cspg5 | Rat | perfluorooctanoic acid | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of CSPG5 mRNA | CTD | PMID:35163327 | Cspg5 | Rat | phenylmercury acetate | decreases expression | ISO | CSPG5 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of CSPG5 mRNA | CTD | PMID:26272509 | Cspg5 | Rat | phenylmercury acetate | multiple interactions | ISO | CSPG5 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CSPG5 mRNA | CTD | PMID:27188386 | Cspg5 | Rat | progesterone | decreases expression | ISO | CSPG5 (Homo sapiens) | 6480464 | Progesterone results in decreased expression of CSPG5 mRNA | CTD | PMID:18037150 | Cspg5 | Rat | propiconazole | decreases expression | ISO | Cspg5 (Mus musculus) | 6480464 | propiconazole results in decreased expression of CSPG5 mRNA | CTD | PMID:21278054 | Cspg5 | Rat | resveratrol | multiple interactions | ISO | CSPG5 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of CSPG5 mRNA | CTD | PMID:23557933 | Cspg5 | Rat | SB 431542 | multiple interactions | ISO | CSPG5 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Cspg5 | Rat | sodium arsenite | increases expression | ISO | CSPG5 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of CSPG5 mRNA | CTD | PMID:29301061 | Cspg5 | Rat | sunitinib | decreases expression | ISO | CSPG5 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of CSPG5 mRNA | CTD | PMID:31533062 | Cspg5 | Rat | temozolomide | increases expression | ISO | CSPG5 (Homo sapiens) | 6480464 | Temozolomide results in increased expression of CSPG5 mRNA | CTD | PMID:31758290 | Cspg5 | Rat | thapsigargin | decreases expression | ISO | CSPG5 (Homo sapiens) | 6480464 | Thapsigargin results in decreased expression of CSPG5 mRNA | CTD | PMID:22378314 | Cspg5 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of CSPG5 mRNA | CTD | PMID:23411599 | Cspg5 | Rat | triphenyl phosphate | increases expression | ISO | Cspg5 (Mus musculus) | 6480464 | triphenyl phosphate results in increased expression of CSPG5 mRNA | CTD | PMID:35752650 | Cspg5 | Rat | Triptolide | decreases expression | ISO | Cspg5 (Mus musculus) | 6480464 | triptolide results in decreased expression of CSPG5 mRNA | CTD | PMID:32835833 | Cspg5 | Rat | triptonide | increases expression | ISO | Cspg5 (Mus musculus) | 6480464 | triptonide results in increased expression of CSPG5 mRNA | CTD | PMID:33045310 | Cspg5 | Rat | valproic acid | affects expression | ISO | CSPG5 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of CSPG5 mRNA | CTD | PMID:25979313 | Cspg5 | Rat | valproic acid | increases expression | ISO | CSPG5 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of CSPG5 mRNA | CTD | PMID:28001369 | Cspg5 | Rat | vinclozolin | affects expression | EXP | | 6480464 | vinclozolin affects the expression of CSPG5 mRNA | CTD | PMID:19015723 | |